SYZYGIUM JAMBOLANUM (HOMEOLAB USA INC.)


Welcome to the PulseAid listing for the SYZYGIUM JAMBOLANUM drug offered from HOMEOLAB USA INC.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: HOMEOLAB USA INC.
NON-PROPRIETARY NAME: SYZYGIUM JAMBOLANUM
SUBSTANCE NAME: SYZYGIUM JAMBOS SEED
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: PELLET
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 1995-10-11
END MARKETING DATE: 0000-00-00


SYZYGIUM JAMBOLANUM HUMAN OTC DRUG Details:

Item DescriptionSYZYGIUM JAMBOLANUM from HOMEOLAB USA INC.
LABELER NAME: HOMEOLAB USA INC.
DEA SCHEDULE:
ACTIVE STRENGTH: 3([hp_X]/1)
START MARKETING DATE: 1995-10-11
END MARKETING DATE: 0000-00-00
PRODUCT ID: 60512-6997_2880f07e-526d-409b-8cbd-3dad8561ca5c
PRODUCT NDC: 60512-6997
APPLICATION NUMBER:

Other SYZYGIUM JAMBOS SEED Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
HOMEOLAB USA INC.SYZYGIUM JAMBOLANUM
Washington Homeopathic ProductsEugenia jambosa